Suggestions
Padmini Srikantiah
Deputy Director at Bill & Melinda Gates Foundation
Padmini Srikantiah is a Deputy Director at the Bill & Melinda Gates Foundation, focusing on global health initiatives.12 Her work primarily revolves around reducing deaths from pneumonia, neonatal sepsis, and meningitis.35
Professional Background
Padmini's role at the Gates Foundation includes:
- Director of Pneumonia and Pandemic Preparedness3
- Working on initiatives to reduce mortality from respiratory diseases and infections in infants and children, particularly in low- and middle-income countries1
- Involvement in research and surveillance studies related to respiratory syncytial virus (RSV) and its impact on infant mortality1
Areas of Focus
Padmini's work encompasses several key areas:
Respiratory Diseases:: She has been involved in studies assessing the burden of RSV in young infants across various countries, including Argentina, India, Pakistan, and Zambia.1
Maternal Immunization:: Padmini has shown interest in the potential of maternal immunization to save newborn lives.3
Antimicrobial Resistance (AMR):: She advocates for innovative approaches to drug discovery and development that prioritize equity and access in addressing AMR.4
Global Health Equity:: Her work often focuses on health issues affecting low- and middle-income countries, emphasizing the importance of community-based studies and surveillance.1
Education
Padmini Srikantiah received her education from the University of California, Berkeley.2
Padmini's work at the Gates Foundation demonstrates a commitment to improving global health outcomes, particularly in the areas of infectious diseases and child mortality in resource-limited settings.
Highlights
I’m proud to have contributed to The Lancet Series on Antimicrobial Resistance.
Each year, an estimated 7.7 million deaths globally are caused by bacterial infections - 1 in 8 of all global deaths. Of these, almost 5 million deaths are associated with bacteria which have developed resistance to antibiotics.
The impact of AMR is greatest in low and middle income countries, where infants and children are disproportionately affected by AMR. Ensuring access to antibiotics and addressing AMR with effective tools, including vaccines and infection prevention, is critical to achieving child health and survival goals.
The Lancet Series on Antimicrobial Resistance comes ahead of the High-Level Meeting of the United Nations General Assembly in September.
#AMR #globalhealth #vaccines #newborns
Read here: hubs.li/Q02xnkq70
The Global Research on Antimicrobial resistance project (GRAM) published in the The Lancet today provides the most comprehensive estimates that we have on the global impact of AMR. This analysis reports a staggering 1.27 million deaths attributed to bacterial AMR in 2019—with the highest burden in low- and middle-income countries (LMICs). These data underscore why our Bill & Melinda Gates Foundation AMR strategy is focused on prevention of mortality due to these AMR priority pathogens in LMICs. We need innovative approaches to prevent infections and deaths due to AMR. #amr https://lnkd.in/gpWyxc8e https://lnkd.in/gBGeD7HJ
